Logo

American Heart Association

  41
  0


Final ID: Mo015

Myeloid Specific PD-L1 Deletion Promotes Cardiac Dysfunction And Myocardial Inflammation

Abstract Body: Background: Immunotherapy, particularly PD-1/PD-L1 blockers, is effective in cancer treatment but can cause rare, but potentially fatal heart issues. Despite the significant impact of these adverse events, there is limited research into the underlying mechanisms of immune checkpoint inhibitor (ICI)-mediated cardiotoxicity. PD-L1, which is abundantly expressed in cardiac tissue, particularly exhibits high expression levels over myeloid cells. However, the precise role of myeloid-specific PD-L1 signaling in mediating autoimmune cardiac disease pathology remains unclear.
Methods and Results: To study the role of myeloid cell-specific PD-L1 (myeloid-PD-L1) in cardiac pathophysiology, we generated myeloid-specific PD-L1 KO mice, using Lyz2tm1(Cre) Ifo systems. As expected, PD-L1 expression was significantly down-regulated in Mφs from myeloid-PD-L1 KOs. The cardiac function was followed by echocardiography. Controls and myeloid-PD-L1-KO hearts had comparable ventricular function at 1 month of age. Interestingly, as early as 2 months of age, myeloid-PD-L1-KOs displayed marked cardiac dysfunction as reflected by reduced LVEF, LVFS, and HF markers. Immune profiling was conducted whether chronic inflammation contributes to cardiac dysfunction and remodeling at a later age as observed at 2 and 3 months of age. Interestingly, excessive systemic inflammation and substantial immune infiltration (innate and adoptive), activation, and a pro-inflammatory cytokine storm were detected in the KO hearts. Furthermore, myeloid-PD-L1 KO hearts showed increased recruitment of pro-inflammatory CCR2+ monocytes and macrophages.
Conclusion: Our data with myeloid-PD-L1 KOs suggest that deleting PD-L1 in myeloid lineage promotes myocardial and systemic inflammation through innate and adaptive immune cell activation and recruitment of CCR2+ MΦs. Subsequently, this leads to impaired cardiac pathophysiology. Thus, these translational studies will directly evaluate the potential of targeting myeloid-PD-L1 signaling to alleviate cardiac damage.
  • Toro Cora, Angelica  ( UAB , Birmingham , Alabama , United States )
  • Sethi, Rohan  ( UAB , Birmingham , Alabama , United States )
  • Zhang, Qinkun  ( UAB , Birmingham , Alabama , United States )
  • Lal, Hind  ( UAB , Birmingham , Alabama , United States )
  • Sultan, Tousif  ( UAB , Birmingham , Alabama , United States )
  • Author Disclosures:
    Angelica Toro Cora: DO NOT have relevant financial relationships | Rohan Sethi: No Answer | qinkun zhang: DO NOT have relevant financial relationships | Hind Lal: DO NOT have relevant financial relationships | Tousif Sultan: DO NOT have relevant financial relationships
Meeting Info:

Basic Cardiovascular Sciences

2024

Chicago, Illinois

Session Info:

Poster Session and Reception I

Monday, 07/22/2024 , 04:30PM - 07:00PM

Poster Session and Reception

More abstracts on this topic:
Ablation of T-Lymphocyte β-Arrestins Reduces Inflammation and Increases Salt Retention in the Absence of Blood Pressure Changes Following Angiotensin II Infusion

Ghobrial Mina, Fekete Eva, Muskus Veitia Patricia, Brozoski Daniel, Lu Ko-ting, Hantke Guixa Ana, Wackman Kelsey, Sigmund Curt, Nakagawa Pablo

Alleviating Aortic Valve Calcification By Blocking TNFα Receptors

Thent Zar Chi, Butcher Jonathan, Zhou Bin

More abstracts from these authors:
δ-catenin mRNA m6A Methylation Promotes Cardiac Fibrosis following Acute Myocardial Infarction

Dutta Roshan, Ranjan Prabhat, Pathak Vasundhara, Colin Karen, Zhang Qinkun, Xie Min, Lal Hind, Young Martin, Verma Suresh

Cardiomyocytes HIPK2 Regulates Myocardial Inflammation And Heart Function Through Purinergic Signaling

Sultan Tousif, Krishnamurthy Prasanna, Lal Hind, Umbarkar Prachi, Sethi Rohan, Toro Cora Angelica, Chen Yunxi, He Jin, Dubey Praveen, Zhang Qinkun, Xie Min

You have to be authorized to contact abstract author. Please, Login
Not Available